Introduction: This study investigated the mRNA expression pattern and distribution of
INTRODUCTION
The neurotransmitter 5-hydroxytryptamine receptors facilitate cholinergic transmission [7] . Other studies showed detrusor contractions through activation of the 5-HT 4 receptors induced by electrical field stimulation [8] and the receptor agonist [9] . The 5-HT 7 receptors have been demonstrated pharmacologically in human detrusor [10] . Additionally, the existence of 5-HT 2A and 5-HT 2B receptors [11, 12] , 5-HT 3A receptors [13] , 5-HT 4 receptors [14, 15] , and 5-HT 7 receptors [16] [17] [18] [19] [20] in several animals has been demonstrated with similar methods. However, in the human urothelium and detrusor layers, the mRNA expression levels and the distributions of these 5-HT receptor subtypes have not been well investigated.
To demonstrate the expression patterns of 5-HT receptor subtypes, we semi-quantitatively estimated the levels of 5-HT 2A , 5-HT 2B , 5-HT 3A , 5-HT 4 , and 5-HT 7 mRNAs within the mucosa of the bladder wall and separately within the urothelium and the detrusor. Based on the mRNA expression levels, we then determined by immunohistochemistry the distribution of the most highly expressed 5-HT receptor subtypes. In addition, we determined if the mRNA expression levels of the 5-HT receptor subtypes within the urothelium of patients with benign prostatic hyperplasia (BPH) were different from the normal urothelium.
METHODS

Patients
This study was performed with the approval of the Ethics Committee of Shinshu University 
RESULTS
Expression Patterns of 5-HT Receptor Subtypes in Normal Urinary Bladders
To investigate expression patterns of the 5-HT receptor subtype mRNAs, the expression of each subtype mRNA was calculated relative to the averaged expression of all of the subtype mRNAs ( Fig. 1 ). In the urothelial layers, expression of 5-HT 2B and 5-HT 7 receptor mRNAs was greater than the other receptor subtype mRNAs (Fig. 1a) . For 5-HT 2B , the relative expression level was 7.98 ± 2.08, and for 5-HT 7 , the relative expression level was 2.44 ± 0.64. The relative mRNA expression of 5-HT 2A , 1.46 ± 0.37, was similar to that for all subtypes (Fig. 1a) . In contrast, the relative mRNA expressions for receptor subtypes 5-HT 3A and 5-HT 4 , 0.34± 0.11 and 0.50 ± 0.19, respectively, were lower than the In the urothelium (a), detrusor (b), and whole mucosa (c), the expression of both 5-HT 2B and 5-HT 7 mRNAs were over twofold greater than the average of all receptor subtype mRNAs. The threshold cycle values of 5-HT 3A receptor mRNA in two patients were undetectable in each layer other subtypes (Fig. 1a) . Within the detrusor layers, the relative mRNA expressions for receptor subtypes 5-HT 2B and 5-HT 7 were also greater than the other subtype mRNAs by 7.28 ± 3.97 and 4.77 ± 3.06, respectively (Fig. 1b) . For the mucosa specimens of normal bladder tissue, which included the urothelium and detrusor, the relative expressions for 5-HT 2B and 5-HT 7 receptor mRNAs were 5.32 ± 2.25 and 3.83 ± 1.65 (Fig. 1c) ; however, for 5-HT 2A , 5-HT 3A , and 5-HT 4 receptors, the relative mRNA expressions were 0.93 ± 0.33, 0.79 ± 0.35, and 0.35 ± 0.08, respectively.
In preliminary immunohistochemical studies, the presence of both 5-HT 2B and 5-HT 7 receptors within the urothelial and detrusor layers is shown (Fig. 2) . In the urothelium, the 5-HT 2B receptors were present within the most apical one or two cell layers, nearest the lumen (Fig. 2a) . The 5-HT 7 receptors were detected within the middle layers of the urothelium (Fig. 2b) . The 5-HT 2B receptors were expressed among the smooth muscle layers in the detrusor (Fig. 2c) , and the 5-HT 7 receptors were expressed within the smooth muscle cells and within the interstitial spaces of these layers (Fig. 2d) .
Expression of 5-HT Receptor mRNAs in the Urothelium of Benign Prostatic Hyperplasia Patients
The relative expression level of each 5-HT receptor subtype mRNA within the urothelium of patients in the BPH group was also determined. As in the normal tissue samples, expressions of both 5-HT 2B and 5-HT 7 receptor mRNAs were greater than the other receptor subtype mRNAs (Fig. 3) . The relative expression levels of 5-HT 2B and 5-HT 7 were 7.76 ± 0.76 and 3.33 ± 0.32, respectively. For receptor subtypes 5-HT 2A , 5-HT 3A , and 5-HT 4 , the relative expression levels were 0.71 ± 0.13, 0.44 ± 0.09, and 0.43 ± 0.06, respectively.
For each receptor subtype, the expression levels of mRNAs within the urothelium of the normal and BPH groups were calculated relative to the averaged expression of both groups (Table 1) (Figs. 1a, 3) , there was no significant difference between the groups (effect size d = 0.21). The relative expression levels of 5-HT 7 in the urothelium of both groups were also higher than the average for all subtype mRNAs (Figs. 1a, 3) ; however, in contrast to 5-HT 2B , expression in the BPH group was significantly greater than in the normal group (P\0.01, effect size d = 0.95).
DISCUSSION
This study documented the presence of 5-HT receptor subtypes expressed within normal urinary bladder tissues taken from patients with bladder cancer and from patients with BPH. In normal urinary bladders, the expressions of both 5-HT 2B and 5-HT 7 mRNAs were higher compared to the 5-HT 2A , 5-HT 3A ,
and 5-HT 3A mRNAs. This expression pattern was found in both the urothelium and detrusor layers.
Thus, we analyzed the immunohistochemical distributions of 5-HT 2B and 5-HT 7 receptors within these tissues. The 5-HT 2B receptors were present in the apical one or two cell layers of the urothelium and among the smooth muscle layers in the detrusor. In contrast, the 5-HT 7 receptors were expressed in the middle layers of the urothelium and within the smooth muscle cells in the detrusor.
In the urothelium of the BPH patients, the expression patterns of 5-HT receptor mRNAs were similar to those of the normal urothelium.
Both 5-HT 2B and 5-HT 7 mRNAs were higher compared to the other subtype mRNAs. The expression levels of 5-HT 2B and 5-HT 4 receptor mRNAs were not significantly different between Ketanserin, a 5-HT 2A receptor agonist, increased maximum and mean urinary flow rates, and decreased urethral pressure profile measurements without serious side-effects in male patients with prostatism [21] . In rats with streptozotocin-induced diabetes mellitus, the 5-HT 2A receptor antagonist sarpogrelate hydrochloride inhibited 5-HT-induced detrusor contractions [22] . Furthermore, the alpha-1 adrenoceptor antagonist naftopidil, which was demonstrated a high affinity to the 5-HT receptors as same as the alpha-1 adrenergic receptors, inhibited bladder contractions through 5-HT 2A and 5-HT 2B receptors in rats with bladder outlet obstruction [23, 24] . These studies and our own results suggest that regulation of 5-HT receptors might provide promising clinical treatments for lower urinary tract symptoms.
In the present study, we did not attempt to examine any potential excitatory effects by either 5-HT 2B or 5-HT 7 receptor agonists; or we did not look for inhibitory effects using these receptor antagonists in human bladder strips.
We also did not investigate any potential relationships between bladder functions measured by video urodynamic studies in BPH patient and the higher mRNA expression level of 5-HT 3A and 5-HT 7 within the urothelium.
While this study had these limitations, we successfully showed the characteristics of 5-HT receptor subtype expression within the human urinary bladder.
CONCLUSION
In normal urinary bladders, the expressions of both 5-HT 2B and 5-HT 7 mRNAs within the whole mucosa were higher compared to the 5-HT 2A , 5-HT 3A , and 5-HT 4 mRNAs. The separate urothelium and detrusor layers 5-HT 7 mRNAs were significantly higher.
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